Gestational protein restriction results in intrauterine growth restriction and hypertension in adult female growth-restricted rats. Enhanced vascular responsiveness to angiotensin II is observed, and blockade of the renin-angiotensin system abolishes hypertension in adult growth-restricted rats, suggesting that the renin-angiotensin system contributes to intrauterine growth restriction-induced hypertension. Moreover, growthrestricted adult rats have higher plasma testosterone levels, and antiandrogen treatment abolishes hypertension, indicating an important role for testosterone. We hypothesized that androgens may play a pivotal role in the enhanced responsiveness to Ang II and hypertension. Female offspring of pregnant rats fed 20% protein (control) or 6% protein diet (protein restricted), at 6 mo of age, were studied. Plasma testosterone and mean arterial pressure in protein-restricted offspring were significantly higher compared to controls. Flutamide treatment (10 mg/kg/day subcutaneously for 10 days) reduced mean arterial pressure in protein-restricted offspring but was without significant effect in controls. Vascular Agtr1/Agtr2 ratio was significantly higher in protein-restricted offspring, an effect that was reversed by flutamide. Flutamide treatment did not have any effect on Agtr1/Agtr2 ratio in controls. Enhanced contractile response to angiotensin II in mesenteric arteries was observed in protein-restricted offspring compared with control. Flutamide treatment reversed the enhanced contractile response to angiotensin II in protein-restricted offspring without significant effect in controls. Vascular reactivity to phenylephrine was similar between the control and protein-restricted offspring with and without flutamide treatment, suggesting that enhanced contractile response and flutamide's reversal effect is specific to angiotensin II. These results suggest that prenatally proteinrestricted rats exhibit an enhanced responsiveness to angiotensin II that is testosterone-dependent.
INTRODUCTION
Suboptimal influences during early life leads to increased risk for cardiovascular disease during adult life [1] [2] [3] [4] [5] [6] [7] [8] [9] . Using a model of protein restriction during rat pregnancy, our laboratory has begun to elucidate the mechanisms linking intrauterine growth restriction and adult life blood pressure [3, [5] [6] [7] . We previously reported that female growth-restricted offspring from protein-restricted dams exhibit a marked increase in arterial pressure in adulthood that is associated with an increase in expression of mesenteric arterial angiotensin (Ang II) receptor, Agtr1a [7] , suggesting that inappropriate activation of the systemic renin-angiotensin system (RAS) is observed in hypertensive adult female protein-restricted offspring. Moreover, blockade of the RAS abolishes hypertension in adult prenatal protein-restricted offspring [7] , suggesting that the RAS contributes to the etiology of hypertension in female protein-restricted offspring; yet, the exact mechanism by which the RAS contributes to hypertension in this model is not clear.
We and others have shown that prenatal protein restriction leads to development of hypertension associated with increase in plasma testosterone levels in the adult females [6, 10] . In these hypertensive females, ovariectomy exacerbated blood pressure to adult male levels, but estradiol replacement only reversed that part of blood pressure increase that was induced by ovariectomy [6] , whereas, antiandrogen treatment completely normalized blood pressure to control levels [3] . Flutamide treatment abolishing hypertension in adult female protein-restricted rats with no significant effect on blood pressure in adult female control rats suggest that hypertension in adult female protein-restricted rats is testosterone dependent [3] . The mechanism by which testosterone modulates blood pressure in adult female protein-restricted rats is not yet elucidated. Furthermore, whether modulation of the RAS by testosterone plays an important role in mediating hypertension induced by prenatal protein restriction in female proteinrestricted offspring is also not known.
A role for modulation of the RAS by testosterone is observed in genetic models of hypertension. Testosterone interacts with the RAS, upregulating the classical constrictor pathway via upregulation of angiotensinogen gene expression, renin activity, and Agtr1 expression [11] [12] [13] . Testosterone is implicated to play a critical role in mediating hypertension in the spontaneously hypertensive rat (SHR) [14] [15] [16] , and modulation of the RAS by testosterone exacerbates hypertension in male SHR [17] . Upregulation of vascular angiotensin receptor expression by testosterone in the SHR may serve as one mechanism by which modulation of the RAS by testosterone contributes to the development of hypertension in the SHR [18] . Androgens also increase Agtr1a receptor mRNA abundance in the abdominal but not thoracic aortas of male mice [19] . However, expression of the renal Agtr1 is not altered by castration in the New Zealand genetically hyperten-sive rat [20] , yet the enhanced pressor response to acute Ang II observed in male New Zealand genetically hypertensive rats is abolished by castration, indicating that increased sensitivity to Ang II is testosterone dependent in this genetic model of hypertension [20] . Furthermore, RAS blockade in male and female SHRs abolishes the sex difference in the arterial pressure observed [17] . Taken together, these data demonstrate that testosterone interacts with the RAS, increasing activation of the classical pathway resulting in Agtr1 activation by Ang II.
A critical role for the RAS is indicated in models of developmental programming of hypertension [7, [21] [22] [23] , and we showed that exaggerated vasomotor responses to Ang II [7] may serve as a potential mechanism. Therefore, the aim of this study was to determine whether the enhanced responsiveness to Ang II and hypertension observed in adult female proteinrestricted rats is testosterone dependent.
MATERIALS AND METHODS

Animals
All the experimental procedures were in accordance with National Institutes of Health guidelines, and our protocol was approved by the Animal Care and Use Committee at the University of Texas Medical Branch. Rats were housed in a temperature-controlled room (238C) with a 12L:12D cycle with food and water available ad libitum. Timed pregnant Sprague-Dawley rats were purchased from Harlan. The rats were allocated to ad libitum isocaloric diet containing either 20% (control, n ¼ 8) or 6% (protein-restricted group, n ¼ 9) casein, as in our previous studies [3, 5, 6] . After the delivery of pups, dams were returned to regular chow. Pups were weaned at 3 wk of age to regular chow, and females were housed separately and examined at 6 mo of age. Blood samples were collected between 0900 and 1000 from control and proteinrestricted offspring on the day of estrus, as determined by vaginal cytology. Plasma was separated by centrifugation and stored at À208C until the time of measurement. A subset of female offspring at 6 mo of age were treated with vehicle or androgen receptor antagonist flutamide (10 mgÁkg À1 Áday À1 subcutaneously) [3] for 10 days. Following flutamide treatment, changes in arterial pressure were determined. After blood pressure measurement, the animals were sacrificed, a portion of the mesenteric arteries were separated for vascular reactivity studies, and the remaining were quickly frozen for RNA isolation and determination of expression of Ang II receptors (Agtr1 and Agtr2). Unless specified otherwise, one animal per litter was used for the different studies.
Experimental Procedures
Plasma testosterone levels. Testosterone levels in the samples were measured using an enzyme imuunoassay radioimmunoassay kit (Enzo Life Sciences) according to the manufacturer's instructions. The minimum detectable concentration of testosterone was 6 pg/ml. The intra-and interassay coefficients of variation were lower than 5%.
Mean arterial pressure. Mean arterial pressure in conscious free-moving female offspring of control and protein-restricted dams was determined at 6 mo of age using indwelling carotid arterial catheters as described in our previous publication [6] . Briefly, rats under anesthesia (ketamine, 45 mg/kg; xylazine, 5 mg/kg) (Burns Veterinary Supply) were surgically instrumented with flexible catheters (polyethylene 50 tubing) in the left carotid artery. The catheters were tunneled to the nape of the neck and exteriorized. After a 24 h recovery period, when the animals are fully conscious and in free-moving state, arterial catheter was connected to a pressure transducer and arterial blood pressure was obtained using a data acquisition system (DBP001 direct BP system and Workbench for Windows software, both from Kent Scientific). Following a 30 min stabilization period, the arterial pressure was monitored continuously for 30 min and averaged to determine the baseline values.
Quantitative real-time PCR. Immediately following the measurements of baseline blood pressure, the whole mesenteric arteries were collected and instantly frozen in liquid nitrogen and later processed for total RNA extraction using TRIzol (Invitrogen). All the RNA isolates were made DNA-free by treatment with DNAse and further purified with RNeasy cleanup kit (Qiagen Inc.). Total RNA concentration and integrity were determined using an ND-1000 Nanodrop spectrophotometer (Thermo Fisher Scientific) and RNA gel. One microgram of total RNA was reverse transcribed using a modified Maloney murine leukemia virus-derived reverse transcript (New England BioLabs Inc.) and a blend of oligo (dT) and random hexamer primers (Invitrogen). The reaction was carried out at 288C for 15 min and 428C for 50 min, then stopped by heating at 948C for 5 min followed by 48C before storage at À208C until further analysis. One microliter of the diluted cDNA corresponding to 100 ng RNA was amplified by real-time PCR using FAM (Invitrogen) as the fluorophore in a CFX96 real-time thermal cycler (Bio-Rad). PCR conditions were 2 min at 508C for one cycle; 10 min at 958C, 15 sec at 958C, and 1 min at 608C for 40 cycles; and a final dissociation step (0.05 sec at 658C and 0.5 sec at 958C). The efficiency of these assays was 100%. Results were calculated using the 2 ÀDDCT method and expressed in fold increase and/or decrease of the gene of interest in protein-restricted versus control rats. All the reactions were performed in duplicate, and 18S was used as an internal control. The following TaqMan assays were done in 10 ll for real-time PCR at a final concentration of 250 nM TaqMan probe and 900nM of each primer; Assayson-Demand for Agtr1a (Rn01435427_m1), Agtr1b (Rn02132799_s1), and Agtr2 (Rn00560677_s1) were obtained from Applied Biosystems.
Ex vivo vascular reactivity studies. Freshly excised third-order mesenteric arteries from 6-mo-old female offspring were placed in ice-cold modified Krebs bicarbonate solution (KBS) of the following composition: 118 mM NaCl, 4.7 mM KCl, 25 mM NaHCO 3 , 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , and 11 mM dextrose. The mesenteric arteries were cleaned of adherent connective tissue and cut into rings of 2 mm length. Two to four rings from one rat were used for one experiment, and the variable n presented with each figure represents the number of animals studied. We have previously shown that protein-restricted offspring have endothelial dysfunction [5] ; hence, studies were done in endothelium-denuded arterial rings to avoid confounding and to assess the Ang II receptor-mediated effects on the vascular smooth muscle. Endothelium was denuded by gently rubbing with tungsten wires. Two 25-lm tungsten wires were threaded through the lumen, and the rings were mounted in an isometric wire myograph system (model 610M wire myography; Danish Myo Technology). The rings were bathed in 6 ml KBS, gassed with 95% oxygen and 5% carbon dioxide, maintained at a temperature of 378C, and allowed to equilibrate for 30 min before normalization to an internal diameter of 0.9 of L 13.3kPa (resting transluminal pressure of 100 mmHg, in vivo) by using a standardized procedure [24] and normalization software package (Myodata; Danish Myo Technology). This corresponds to a transmural pressure of ;90 mmHg. Following normalization, rings were repeatedly exposed to 80 mM KCl to test their viability and to determine a standard contractile response for each of them. The rings were contracted with a a 1 -adrenergic receptor agonist, 3 lM phenylephrine (Sigma), and when responses were stable, endotheliumdenudation was confirmed by absence of relaxation to 10 lM acetylcholine (Sigma). Rings were then allowed to recover for 60 min, after which cumulative concentration-response curves were generated with Ang II (10 À13 to 10 À8 M) (Sigma) and phenylephrine (10 À9 to 10 À5 M).
Statistical Analysis
For the comparison of arterial pressure and gene expression, analysis was performed using two way ANOVA (diet and flutamide treatment as factors), with adjustments for multiple comparisons. Cumulative concentration-response curves were analyzed by computer fitting to a four-parameter sigmoid curve using the Prism 5 program (GraphPad) to evaluate the half-maximal effective concentration (pD2 ¼ Àlog half-maximal concentration) and the maximum asymptote of the curve (E max ). All the values are expressed as means 6 SEM, and a P , 0.05 was considered significant.
RESULTS
Plasma Testosterone Levels
Plasma testosterone levels significantly increased by 2.4-fold in adult female protein-restricted offspring (135 6 19.93 pg/ml, n ¼ 7) compared to controls (59 6 8.96 pg/ml, n ¼ 5, P , 0.05).
Mean Arterial Pressure
Mean arterial pressure measured in conscious free-moving rats via indwelling carotid catheter was significantly higher in protein-restricted females (116 6 3.6 mmHg, n ¼ 8) compared to controls (98 6 2.4 mmHg, n ¼ 8, P , 0.05; Fig. 1 ). Flutamide treatment significantly decreased the blood pressure in protein-restricted females (106 6 1.4 mmHg, n ¼ 8, P , 0.05) and was without significant effect in controls (105 6 2.9 mmHg, n ¼ 8; Fig. 1 ).
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Expression of Agtr1 and Agtr2 Receptors in the Mesenteric Artery
At the mRNA level, rodents possess two Agtr1 receptor isoforms, designated Agtr1a and Agtr1b. Agtr1b was undetectable in the rat mesenteric arteries, which is similar to the finding in previous studies [7, 25] . The mesenteric vascular expression of Agtr1a mRNA was 2-fold higher in proteinrestricted rats compared to control (n ¼ 6 in each group, P , 0.05; Fig. 2A ). Agtr2 mRNA was similar between control and protein-restricted females (n ¼ 6 in each group; Fig. 3B ). The vascular Agtr1a/Agtr2 ratio was significantly higher by 2.0-fold in protein-restricted females compared with control females (n ¼ 6; Fig. 2C ).
Flutamide significantly decreased Agtr1a (n ¼ 6, P , 0.05; Fig. 2A ) and increased Agtr2 (n ¼ 6, P , 0.05; Fig. 2B ) mRNA expression in the mesenteric arteries of protein-restricted females compared to vehicle-treated protein-restricted females (n ¼ 6 in each group, P , 0.05; Fig. 2A ). Flutamide did not affect Agtr1a and Agtr2 mRNA expression in the controls (n ¼ 6 in each group; Fig. 2, A and B) . Thus, flutamide significantly decreased mesenteric arterial Agtr1a/Agtr2 ratio in proteinrestricted females and was without significant effect in controls (n ¼6, P , 0.05; Fig. 2C ).
Ex Vivo Vasomotor Responses
Ang II induced a dose-dependent increase in contractile responses in mesenteric arterial rings. However, the Ang IIinduced contractile responses were exaggerated with a leftward shift in the dose-response curves as well as an increase in maximal responses in the protein-restricted (pD2 ¼ 10. Flutamide treatment reversed the enhanced contractile response to angiotensin II in protein-restricted females (pD2 ¼ 9.18 6 0.14, E max ¼ 28.21 6 2.62, n ¼ 6) with no significant effect in controls (pD2 ¼ 9.29 6 0.14, E max ¼ 25.95 6 3.97, n ¼ 6; Fig. 3 ). Contractile responses to phenylephrine (n ¼ 5 in each group; Fig. 4) were not increased in protein-restricted females compared to controls. Flutamide treatment did not affect contractile responses to phenylephrine in both proteinrestricted and control females (n ¼ 5 in each group; Fig. 4 ).
DISCUSSION
This study tested the hypothesis whether testosterone contributes to the enhanced responsiveness to Ang II and hypertension observed in adult female protein-restricted rats. The main findings indicate that not only increased blood pressure, but the enhanced mesenteric vasomotor response mediated by Ang II in female protein-restricted rats is abolished by flutamide. The increased Agtr1a expression and Agtr1a/Agtr2 ratio in the mesenteric arteries of proteinrestricted females was also reversed by flutamide. Importantly, the vascular contractile responses to another vasoconstrictor, phenylephrine, was not altered by flutamide, suggesting that flutamide's reversal of contractile effect is specific to Ang II. Therefore, we suggest that testosterone may regulate increases 
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in vascular Agtr1 and Ang II stimulated responses to mediate increase in blood pressure in the female offspring that are exposed to prenatal protein restriction.
It is now well-established that a variety of insults, when experienced in the prenatal period, can have long-term influences on the health of the individual. Consistent with previous reports [6, 10] , prenatal protein-restricted adult females have increased plasma testosterone levels. This increased testosterone levels in protein-restricted females is of both ovarian and extraovarian origin and is associated with increased blood pressure [3, [5] [6] [7] similar to that observed in this study. As reported previously by our group [3] and now confirmed by direct carotid artery catheter, blood pressure was significantly reversed by antiandrogen flutamide, suggesting that hypertension in adult protein-restricted females is androgen receptor dependent.
RAS, a regulatory system important in the long-term control of blood pressure, is altered in the offspring of proteinrestricted dams, and is shown to contribute to the etiology of programmed hypertension. Consistently, we and others have shown that blocking of Ang II formation with angiotensin converting enzyme blocker [26] or inhibition of Ang II action at Ang II type-1 receptor (AT 1 R) with antagonist [7, 27] prevents elevation of blood pressure in the offspring of proteinrestricted dams. We not only confirm that prenatal protein restriction leads to exaggerated mesenteric vascular responses to Ang II in the adult females [7] , but we also provide novel data that treatment with a selective androgen receptor antagonist, flutamide, abolished the exaggerated mesenteric vascular responses to Ang II. This finding suggests that the enhanced responsiveness to Ang II in female protein-restricted rats is testosterone dependent and, importantly, indicates that involvement of the RAS in prenatal protein restriction-induced hypertension may necessitate modulation by testosterone. Similar responses of testosterone-dependent enhancement in responsiveness to Ang II is observed in adult growth-restricted male rats born to pregnant rats with reduced uterine perfusion [28] .
The finding that increased expression of Agtr1a in the mesenteric arteries was reversed by flutamide suggests that testosterone may mediate the enhanced sensitivity to Ang II in female protein-restricted rats through upregulation of Agtr1a-mediated mechanisms. There are evidences that Agtr1 expression is androgen dependent. In rat epididymis, castration reduced Agtr1 receptor protein that was restored when rats were treated with testosterone [29] . Moreover, androgen was reported to increase Ang II receptors in bovine adrenal glomerulosa cells [30] . In addition, incubation of human prostate cancer cells with androgens increased Agtr1 receptor expression [31] , supporting androgens regulation of Agtr1. However, the mechanism by which androgens regulate Agtr1 expression has been relatively unexplored. Possible mechanisms of testosterone-dependent upregulation of Agtr1a receptor mRNA expression include modulation of receptor transcription through androgen response elements. Preliminary analysis of Agtr1 promoter reveals the presence of partial androgen response elements [30] . Androgens may also activate Agtr1 transcription from alternative response elements such as the glucocorticoid response element [32, 33] by enhancing assembly of general transcription factors, including TATAbox-binding protein [34] , stimulating activator protein-1, nuclear Factor-KappaB [35, 36] , or increasing mRNA stability [37] . In addition to stimulating receptor mediated effects, testosterone may activate Agtr1 postreceptor mechanisms [38] . Testosterone is shown to potentiate renal vascular responses to Ang II partially through upregulation of the Rho kinasesignaling pathway [39] . Whether testosterone-modulated control of Rho kinase or other downstream-signaling pathways contributes to the enhanced responsiveness to acute Ang II in the female protein-restricted rats is unknown. Thus, testosterone-dependent hypertension mediated via modulation of the RAS may involve both receptor and postreceptor mechanisms.
Actions of the Agtr2 are less clear but seem to counterbalance some of the actions of the Agtr1 leading to vasodilation [40] . The reason for this specific increase in Agtr2 expression in flutamide-treated protein-restricted females is unclear and is an area of future investigation. Studies indicate that the Agtr1a/ Agtr2 ratio plays a crucial role in the development of the hypertensive phenotype [18] , and the vascular Agtr1/Agtr2 ratio relates to the magnitude of blood pressure elevation observed in SHR rats [18] . Generation of nitric oxide has been implicated in mediating the effects related to Agtr2 actions [41] In the present study, we demonstrated that flutamide significantly reversed the increased mesenteric arterial ratio of Agtr1/Agtr2 in female offspring relating to the magnitude of blood pressure decrease.
Evidence indicates that androgens can contribute to blood pressure control in women because young women with conditions such as polycystic ovarian syndrome, women after menopause, and African-American women have higher plasma testosterone levels, and the frequency of hypertension is greater in these populations. In this study, higher testosterone levels during adult life significantly increases blood pressure. We have shown that increased Agtr1 expression plays a role in the hypertensive activity of androgen. Regulation of Agtr1 expression by androgens via the androgen receptor has significant functional consequences because we determined that androgens exert a significant increase in Ang II-mediated vasoconstriction. The exact mechanism(s) responsible for testosterone modulation of the RAS in this model of hypertension is not clear but the finding that flutamide treatment attenuated mesenteric arterial sensitivity to Ang II with associated decrease in Agtr1a expression in female protein-restricted rats suggest that testosterone potentiates sensitivity to Ang II via its receptor-mediated mechanisms. Further studies are needed to clarify the complex pathways that mediate hypertension and Ang II sensitivity in adult female protein-restricted offspring. Importantly, experimental studies investigating the role of sex hormones in mediating hypertension programmed in response to fetal insult may provide insight into the critical mechanisms linking sex hormones and factors key to the long-term control of blood pressure.
